All articles tagged with #menstrual blood
New studies show menstrual fluid speeds skin wound healing, may enable noninvasive cervical cancer screening with high sensitivity, can help detect endometriosis with a simple test strip, and contains stem cells with regenerative potential for infertility and neurological conditions, suggesting period blood could become a valuable biomedical resource rather than waste.
Researchers are turning menstrual blood into a noninvasive diagnostic tool that could reveal endometriosis and other uterine-related conditions, while also indicating risks for diabetes, autoimmune diseases, ageing, and environmental exposures. Startups like NextGen Jane are identifying endometriosis biomarkers in menstrual samples, and others such as Qvin and theblood are testing at-home kits to assess diabetes risk and infections from period blood. The field faces challenges including sample variability, stigma, and limited funding for women's health research, but advances from MIT and emerging menstrual biobanks are accelerating progress toward quicker diagnosis, better prevention, and a broader understanding of female health.
A BMJ study in 3,068 Chinese women found that menstrual blood collected on a sanitary pad and strip could detect HPV and CIN2/3 with about 94.7% sensitivity, comparable to clinician-collected samples (≈92.1%), though specificity was lower. Negative predictive value and referral rates were similar between methods. The results suggest menstrual-blood testing could become a standardized, non-invasive alternative or supplement to cervical screening, but larger, more diverse trials are needed before clinical adoption.
A BMJ study of over 3,000 women suggests HPV testing using menstrual blood collected on mini-pads could nearly match clinician-taken samples in detecting cervical cancer and offers a more convenient at‑home option, potentially improving access and privacy. However, it is not yet ready to replace standard screening, being applicable only to those who menstruate, and requires further validation in diverse groups and with biopsy-confirmed outcomes.
Innovative startups and research groups are exploring the potential of menstrual blood as a noninvasive, at-home diagnostic tool for gynecological conditions like endometriosis, leveraging its unique cellular and molecular content to improve early detection and treatment, despite current funding and societal challenges.
Innovative diagnostic tools like Qvin's FDA-cleared Q-Pad and the upcoming NextGen Jane Smart Tampon aim to speed up and simplify the diagnosis of endometriosis by analyzing menstrual blood for biomarkers, potentially reducing the current 4-11 year delay and invasive surgeries, and empowering women to monitor their reproductive health more easily.
Menstrual stem cells, particularly endometrial stromal mesenchymal stem cells, have been identified as a valuable source of adult stem cells with potential applications in regenerative medicine and women's health. These cells have shown promise in diagnosing endometriosis and treating gynecological diseases, as well as potential therapeutic applications in conditions such as diabetes and wound healing. Research into the use of menstrual stem cells is still in its early stages, but it represents an exciting new frontier in regenerative medicine and could offer noninvasive diagnostic and therapeutic options for various health conditions.
Health tech startups like NextGen Jane, LifeStory Health, and Qvin are revolutionizing the way menstrual blood is perceived and utilized. By collecting and analyzing menstrual effluent, these companies aim to uncover valuable biomarkers and improve healthcare for individuals with uteruses. Menstrual blood, once considered medical waste, is now seen as a potential diagnostic tool for conditions like endometriosis, infertility, thyroid health, diabetes management, and even cancer detection. At-home collection kits and direct-to-consumer models are being developed, but experts emphasize the importance of involving healthcare practitioners to ensure proper guidance and care. The future holds promising possibilities for menstrual-blood testing, with potential applications in various reproductive pathologies.
Researchers at the Feinstein Institutes for Medical Research have been working for six years to find a way to diagnose endometriosis that does not require surgery. They believe they have found the answer in menstrual blood. By collecting just a small amount of menstrual blood on a sponge and then analyzing it, they have been able to document differences in the menstrual blood of people with endometriosis. Late last year, they began a new clinical trial focused on people who are preparing to undergo laparoscopic surgery. The goal of the trial is to see if menstrual blood analysis can be used as a way to screen people for endometriosis.